Teribone subcutaneous injection 56.5μg, by Asahi Kasei Pharma, contains teriparatide acetate. This synthetic human parathyroid hormone preparation promotes bone formation and increases bone mass, typically used for osteoporosis patients at high risk of fracture. It is available as 56.5μg 1 bottle (YJ code: 2439401D1028).
Teribone subcutaneous injection 56.5μg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →